Circulating Innate Lymphoid Cell Type 2 (ILC2) Levels and Asthma: a Case-control Study
NCT03128762 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36
Last updated 2017-05-01
Summary
The primary objective of this study is to demonstrate differences in ILC2 blood levels between asthma patients and control patients.
Conditions
Interventions
- BIOLOGICAL
-
ILC2 levels in blood
The levels of circulating ILC2 cells relative to other lymphocytes will be determined via flow cytometry
Sponsors & Collaborators
-
University Hospital, Montpellier
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-06-25
- Primary Completion
- 2015-04-14
- Completion
- 2015-06-23
More Related Trials
-
Community Based Study of Adult Onset Asthma
NCT00005544 ·Status: COMPLETED
-
Remote Monitoring of Asthma in Children and Young People
NCT07129616 ·Status: RECRUITING
-
Markers of Airway Inflammation in BAL Fluid From Children With Asthma
NCT00838552 ·Status: COMPLETED
-
Blood Lymphocytes in Asthmatics Treated With Therapeutic Proteins
NCT04514926 ·Status: COMPLETED
-
Analysis of Peripheral Blood ILC2s and Th2 Cells in Response to ANB020
NCT04256044 ·Status: COMPLETED
-
Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma: Influence of Systemic IL-5 Targeting
NCT05689931 ·Status: UNKNOWN
-
Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics
NCT00721097 ·Status: TERMINATED
-
The Use of Inflammatory Markers to Guide Therapy in Children With Severe Asthma
NCT00262340 ·Status: COMPLETED ·Phase: NA
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Omalizumab Compared to Non-Omalizumab Treatment in Asthma Patients
NCT02921178 ·Status: UNKNOWN
-
Retrospective Study for Description of The Use Of Omalizumab In Patients With Difficult To Control Asthma
NCT01397760 ·Status: UNKNOWN
-
Aspirin for Uncontrolled Asthma
NCT02906761 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma
NCT01078688 ·Status: COMPLETED
-
An Investigation of Tumor Necrosis Factor (TNF)-Alpha in Asthma Using Biopsy Explants and Primary Bronchial Epithelial Cell Cultures
NCT01161303 ·Status: COMPLETED
-
Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects
NCT06015256 ·Status: RECRUITING ·Phase: NA
-
Clinico-biological Correlation of Severe Asthma in Children
NCT02038374 ·Status: UNKNOWN ·Phase: NA
-
Lung Fluid and Peripheral Blood Neutrophil IL-5 Surface Receptor in Children With Asthma
NCT02866487 ·Status: COMPLETED
-
Detection of Cav1 Calcium Channels in Inflammatory Cells of Asthmatic Children
NCT02809560 ·Status: COMPLETED ·Phase: NA
-
Asthma in Children
NCT01286532 ·Status: COMPLETED
-
The Development of a Clinical Test to Assess the Inflammatory Phenotype of Asthma
NCT01611012 ·Status: COMPLETED
-
Cohort Analysis of Clinical and Biological Severe Childhood Asthma
NCT02114034 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma
NCT01007149 ·Status: COMPLETED ·Phase: PHASE3
-
Asthma Biomarker Study
NCT02392481 ·Status: COMPLETED
-
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
NCT05270278 ·Status: COMPLETED
-
The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma
NCT00133042 ·Status: COMPLETED ·Phase: PHASE4